Our vision
Moving diagnostic frontiers in dermatology.
Our mission
We build leading innovative molecular diagnostic solutions at scale and at point of need for diagnostic laboratories, dermatologists and academic and pharmaceutical research organizations. With our quick, precise and automated tests, we enable skin experts to recommend the best treatments for human skin health.
Company history
Dermagnostix was founded as a spin-off from the Hahn-Schickard Institut in Freiburg, the Helmholtz Zentrum München (HMGU) and TU Munich, after decades of top-level research in dermatology, immunology, bioinformatics and microfluidics. We are located in Southern Germany (Freiburg).
Game-changing modern therapies have evolved the treatment of inflammatory disease and skin cancer. Diagnostics have not kept pace with these therapeutic advances. Dermagnostix closes this gap bringing objective molecular results directly to the physician.
Management
Sarah Dion, MBA
Chief Strategy Officer
Natalie Garzorz-Stark, MD, PhD, MHBA
Chief Executive Officer and Co-Founder of Dermagnostix
Ludwig Gutzweiler
Chief Technology Officer
Martin Meyer
Head of Production and SCM
Isabelle Meyer-Garzorz, PhD
Chief Operating Officer
Board
Professor and Chair in Dermatology, Co-founder of Dermagnostix.
Friedrich Hecker
Non-Executive Board Member, Senior Advisor, Startup Investor.
Martin Klässner
Serial Entrepreneur and Investor with Software-as-a-Service background in the domains Energy, Medical and Robotics.
Prof. Helmut Laaff, MD
Dermatopathologist, Owner IDPM Freiburg Group, Professor Department Chemistry and Pharmacy University Freiburg.
Translational Research Inflammatory Skin Diseases, University Medical Center Hamburg; Medical Director JeruCON GmbH.
Prof. Roland Zengerle, PhD
Professor for MEMS applications, University of Freiburg; Executive Board member of Hahn-Schickard.
Scientific advisors
Katharina Dormanns, PhD
Microfluidics Engineer and Co-Founder of Dermagnostix.
Prof. Stefanie Eyerich, PhD
Professor for Functional Allergology and Co-Founder of Dermagnostix.
Prof. Christoffer Gebhardt, MD
Professor for Dermato-Oncology and Co-Founder of Dermagnostix.
Michael Howell, PhD
Immunologist, Biotech Entrepreneur, Translational Science and Biomarker Leader in Oncology, Inflammation and Immunology.
Nils Paust, PhD
Microfluidics Engineer, Associate Director of the Hahn-Schickard Institute of Microanalysis Systems and Co-Founder of Dermagnostix.
Prof. Fabian Theis, PhD, PhD
Mathematician, Physicist, Pioneer in Biomedical AI and Machine Learning and Co-Founder of Dermagnostix.
Dermagnostix, a spin-off company of
Awards
2023
2022
2022
2021
2020
2020
2020
2020
2020
2020
2019
2018
Certification
Since November 2022 Dermagnostix is officially EN ISO 13485 certified
view certificate
Member of
